CPRX: Catalyst Pharmaceuticals, Inc. Stock

by  •  • Comments Off on CPRX: Catalyst Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 2,605.10
Enterprise Value ($M) 2,087.54
Book Value ($M) 727.63
Book Value / Share 5.99
Price / Book 3.58
NCAV ($M) 499.83
NCAV / Share 4.12
Price / NCAV 5.21

Profitability (mra)
Return on Invested Capital (ROIC) 0.22
Return on Assets (ROA) 0.25
Return on Equity (ROE) 0.29

Liquidity (mrq)
Quick Ratio 5.01
Current Ratio 5.17

Balance Sheet (mrq) ($M)
Current Assets 623.61
Assets 851.41
Liabilities 123.78
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 491.73
Operating Income 195.12
Net Income 163.89
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 239.81
Cash from Investing -0.56
Cash from Financing 140.66

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Flynn James E 2.63 -49.71
11-08 13G/A BlackRock, Inc. 16.00 0.00
10-17 13G/A State Street Corp 4.80 -16.24

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-06 10-Q 4r UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [Mark One] ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2024 OR ☐ TRANSITION REPOR

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-11 197,569 889,860 22.20
2025-04-10 246,134 1,347,098 18.27
2025-04-09 323,225 1,627,383 19.86
2025-04-08 279,493 1,374,173 20.34
2025-04-07 243,374 1,974,845 12.32

(click for more detail)

Similar Companies
COEP – Coeptis Therapeutics Holdings, Inc. CORT – Corcept Therapeutics Incorporated
COYA – Coya Therapeutics, Inc. CRBP – Corbus Pharmaceuticals Holdings, Inc.
CRDF – Cardiff Oncology, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Catalyst Pharmaceuticals